The probiotic industry was not affected and did not slow down in its development during the COVID-19 pandemic. Jordan expressed optimism about the vibrant Chinese market after the pandemic. He said Chinese consumers pay more attention to their health, and how probiotic products improve life quality.

The Outline of the 14th Five Year Plan proposed to accelerate the development of the bioeconomy and regards it as one of the important tasks for China to promote and upgrade economic and social transformation.

Jordan said OneHealth will be committed to becoming a part of this upgrade and transformation, adding new energy into the development of the industry. It will explore biotechnology solutions in different segments to help Chinese consumers have a healthier and better life.